东阳祥昇医药科技

Dongyang Xiangsheng Pharmaceutical Technology is a research and development-focused subsidiary of Hengdian Group Tospo Pharmaceutical, based in Dongyang, China. Established in 2021, the company specializes in the technical development, process optimization, and synthesis of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). It primarily focuses on small molecule therapeutics, providing essential R&D services such as technology transfer and technical consultation to the broader pharmaceutical industry. As a key component of the Hengdian Group's healthcare division, the company bridges the gap between laboratory-scale chemical research and industrial manufacturing. Xiangsheng Pharmaceutical operates within the Zhejiang Provincial High-tech Industrial Park, leveraging advanced chemical engineering capabilities to support drug development pipelines.